Goldman Sachs’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-218,481
| Closed | -$649K | – | 4686 |
|
|
2016
Q3 | $649K | Sell |
218,481
-63,935
| -23% | -$190K | ﹤0.01% | 3285 |
|
|
2016
Q2 | $421K | Sell |
282,416
-12,275
| -4% | -$18.3K | ﹤0.01% | 3426 |
|
|
2016
Q1 | $1.09M | Buy |
294,691
+195,186
| +196% | +$722K | ﹤0.01% | 2836 |
|
|
2015
Q4 | $1.01M | Sell |
99,505
-82,903
| -45% | -$837K | ﹤0.01% | 2892 |
|
|
2015
Q3 | $2.48M | Sell |
182,408
-49,532
| -21% | -$674K | ﹤0.01% | 2420 |
|
|
2015
Q2 | $4.4M | Sell |
231,940
-203,369
| -47% | -$3.86M | ﹤0.01% | 2136 |
|
|
2015
Q1 | $11.4M | Sell |
435,309
-452,311
| -51% | -$11.8M | ﹤0.01% | 1599 |
|
|
2014
Q4 | $18.6M | Buy |
887,620
+585,725
| +194% | +$12.3M | 0.01% | 1329 |
|
|
2014
Q3 | $10.1M | Buy |
301,895
+196,975
| +188% | +$6.57M | ﹤0.01% | 1609 |
|
|
2014
Q2 | $3.37M | Sell |
104,920
-77,109
| -42% | -$2.47M | ﹤0.01% | 2234 |
|
|
2014
Q1 | $8.41M | Buy |
182,029
+26,361
| +17% | +$1.22M | ﹤0.01% | 1690 |
|
|
2013
Q4 | $11M | Buy |
155,668
+147,977
| +1,924% | +$10.5M | ﹤0.01% | 1526 |
|
|
2013
Q3 | $660K | Sell |
7,691
-4,706
| -38% | -$404K | ﹤0.01% | 3171 |
|
|
2013
Q2 | $785K | Buy |
+12,397
| New | +$785K | ﹤0.01% | 2926 |
|